scPharmaceuticals (SCPH) Announces Proposed Underwritten Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Wall St set for subdued open as tech rally pauses before Warsh's speech
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil drifts lower as Hormuz flows balance slow progress in Iran diplomacy
- Dollar heads for weekly gain as Warsh remarks awaited
- Chevron stock rises on report of Venezuela oil deal talks
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Ovintiv adds 41,000 acres in Permian and Montney deals
- Russia says it could strike UK military targets in response to Kyiv's use of British missiles
scPharmaceuticals Inc. Announces Proposed Underwritten Public Offering of Common Stock
May 20, 2020 4:01 PM EDTBURLINGTON, Mass.--(BUSINESS WIRE)-- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that it has commenced an underwritten public offering of shares of its common stock. All shares of common stock to be sold in the offering will be offered by scPharmaceuticals. In addition, the underwriters will have a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the... More
